IRIS
LARCHER, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.155
EU - Europa 1.429
AS - Asia 1.008
SA - Sud America 125
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 21
Totale 4.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.056
RU - Federazione Russa 793
SG - Singapore 422
IT - Italia 288
CN - Cina 261
BR - Brasile 96
HK - Hong Kong 91
DE - Germania 81
VN - Vietnam 74
CA - Canada 57
BD - Bangladesh 55
FR - Francia 44
GB - Regno Unito 42
IN - India 40
SE - Svezia 35
NL - Olanda 33
FI - Finlandia 31
PL - Polonia 22
MX - Messico 15
JP - Giappone 12
ZA - Sudafrica 11
IE - Irlanda 10
AT - Austria 9
ID - Indonesia 9
IQ - Iraq 8
CR - Costa Rica 7
EC - Ecuador 7
AR - Argentina 6
BE - Belgio 6
ES - Italia 6
KR - Corea 6
LT - Lituania 6
PT - Portogallo 6
GT - Guatemala 5
JM - Giamaica 5
TR - Turchia 5
CO - Colombia 4
MY - Malesia 4
UA - Ucraina 4
PH - Filippine 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
PY - Paraguay 2
RO - Romania 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
MA - Marocco 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.739
Salva come PNG Salva come JPEG
Città #
Singapore 253
Ashburn 228
San Jose 153
Dallas 140
Moscow 131
Hong Kong 88
New York 88
Milan 82
Los Angeles 64
Beijing 50
Council Bluffs 46
Phoenix 46
Shanghai 41
Munich 32
Hefei 31
Boardman 29
Ho Chi Minh City 27
Atlanta 24
Lauterbourg 24
Rome 24
Santa Clara 23
Denver 19
Turku 19
Montreal 18
Warsaw 17
Orem 16
Hanoi 14
Frankfurt am Main 13
Amsterdam 12
Nuremberg 12
Johannesburg 11
Brooklyn 10
Buffalo 10
Falkenstein 10
North Bergen 10
São Paulo 10
Toronto 10
Chennai 9
Dublin 9
San Francisco 9
Tokyo 9
Bar Harbor 8
Bologna 8
Helsinki 8
Miano 8
Poplar 8
Pune 8
Seattle 8
Chicago 7
Houston 7
Mexico City 7
Mumbai 7
Naples 7
Turin 7
Bari 6
Columbus 6
Guangzhou 6
Hyderabad 6
London 6
Manchester 6
Stockholm 6
Vienna 6
Brussels 5
Frisco 5
Guatemala City 5
Lawrence 5
Miami 5
Princeton 5
San José 5
The Dalles 5
Washington 5
Wroclaw 5
Ankara 4
Boston 4
Catania 4
Lappeenranta 4
Las Vegas 4
Memphis 4
Querétaro 4
Rio de Janeiro 4
Acalanes Ridge 3
Barnet 3
Belo Horizonte 3
Birmingham 3
Biên Hòa 3
Brescia 3
Bến Tre 3
Cologne 3
Figino 3
Genoa 3
Georgetown 3
Guayaquil 3
Haiphong 3
Kansas City 3
Kingston 3
Lisbon 3
Orange Park 3
Pisa 3
Pyeongtaek-si 3
Riyadh 3
Totale 2.159
Salva come PNG Salva come JPEG
Nome #
Recurrent pregnancy loss: a male crucial factor—A systematic review and meta-analysis 958
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 194
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 152
Pulmonary lesion after surgery for renal cancer: progression or new primary? 151
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 144
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 142
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 142
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease 141
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 137
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 135
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 132
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 131
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 130
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 128
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 125
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 122
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 119
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 116
Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action 114
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 110
A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer 109
Influences of Age and Comorbidities on Indication for Partial Nephrectomy: A Systematic Review 108
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 103
Head-to-head comparison of nephrometry scores for partial nephrectomy: implications for clinical guidelines 93
Biological characterization of renal masses using immuno-PET 87
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 86
RADIOMIC AND GENOMIC APPROACHES FOR THE ENHANCED DIAGNOSIS OF RENAL CANCER (REDIRECT): A TRANSLATIONAL PILOT STUDY 84
Technical and Functional Validation of a Teleoperated Multirobots Platform for Minimally Invasive Surgery 83
Enhancing surgical process modeling for artificial intelligence development in robotics: The saras case study for minimally invasive procedures 78
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye 72
Reply to Angela Estevez, Phillip Kim, Peter Chang, and Andrew A. Wagner's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol 2024;85:63–71 63
To clamp or not to clamp? A step back to go forward 54
Intra- and inter-tumoural heterogeneity in von Hippel–Lindau disease-related renal cancer: a multimodal data study protocol 54
Reply to Jared P. Schober, Robert Wang, and Alexander Kutikov's Letter to the Editor re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis. Eur Urol. 2023;85:63–71 52
Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study 28
Surgery or Comorbidities: What Is the Primum Movens of Kidney Dysfunction After Nephrectomy? A Multicenter Study in Living Donors and Cancer Patients 23
Risk Analysis of Retinal Hemangioblastomas in Nonadvanced Stages of von Hippel-Lindau Syndrome Using Ultra-widefield Imaging: The ULTRA von Hippel-Lindau Study 19
A preoperative Artificial Intelligence model to estimate cancer-specific mortality in nonmetastatic kidney cancer patients 17
Acute kidney injury (AKI) and end stage kidney disease (ESKD) in CKD patients undergoing partial or radical nephrectomy for renal cancer: are we ready to unravel the uncertainty and create new hope? 17
Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center 15
Adjuvant pembrolizumab plus belzutifan versus placebo in clear cell renal cell carcinoma: a reconstructed survival data analysis of the KEYNOTE-564 and the LITESPARK-022 trials 15
Impact of Body Mass Index on Renal Function Impairment in Patients Treated for Renal Cell Carcinoma at High Risk of Recurrence: Key Implications for Systemic Therapy Eligibility 12
Removing Barriers to the Use of Systemic Agents for Patients with von Hippel-Lindau Disease 12
Prognostic Impact of Initial Management Strategies in Metachronous Oligometastatic Renal Cell Carcinoma: A Real-World Evidence 11
Multidisciplinary team referral at diagnosis for patients with non-metastatic renal cell carcinoma 8
Real-world challenges and considerations in treating von Hippel-Lindau disease with HIF-2α inhibitors 7
Cytoreductive Nephrectomy in 2021: Obsolete but Necessary 5
Predicting the Risk of Progression in Patients with Kidney Cancer: Aiming at the Optimal Tool in the Optimal Setting 5
Totale 4.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.389
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227 0 0 0 0 0 0 0 1 0 1 0 5
2022/202368 11 9 4 4 4 8 4 8 2 2 1 11
2023/2024220 14 9 20 13 14 46 1 36 5 6 15 41
2024/2025621 54 17 35 49 45 40 89 64 88 34 39 67
2025/20262.563 157 125 119 290 246 83 201 229 676 139 88 210
2026/20271.364 670 147 237 310 0 0 0 0 0 0 0 0
Totale 4.843